RT Journal Article SR Electronic T1 Infodemiological study of COVID-19 in Latin America and The Caribbean JF medRxiv FD Cold Spring Harbor Laboratory Press SP 2020.08.11.20173054 DO 10.1101/2020.08.11.20173054 A1 Carlos Jesús Aragón-Ayala A1 Julissa Copa-Uscamayta A1 Luis Herrera A1 Frank Zela-Coila A1 Cender Udai Quispe-Juli YR 2020 UL http://medrxiv.org/content/early/2020/08/14/2020.08.11.20173054.abstract AB Background Infodemiology has been widely used to assess epidemics. In light of the recent pandemic, we use Google Search data to explore online interest about COVID-19 and related topics in 20 countries of Latin America and the Caribbean.Method Data from Google Trends from 2019/12/30 to 2020/04/25 regarding COVID-19 and other related topics were retrieved and correlated with official data on COVID-19 cases and with national epidemiological indicators.Results The Latin American and Caribbean countries with the most interest for COVID19 were Peru (100%) and Panama (98.39%). No correlation was found between this interest and national epidemiological indicators. The global and local response time were 20.2±1.2 days and 16.7±15 days, respectively. The duration of public attention was 64.8±12.5 days. The most popular topics related to COVID-19 were: the country’s situation (100 ± 0) and coronavirus symptoms (36.82±16.16). Most countries showed a strong or moderated (r=0.72) significant correlation between searches related to COVID-19 and daily new cases. In addition, the highest significant lag correlation was found on day 13.35±5.76 (r=0.79).Conclusions Interest shown by Latin American and Caribbean countries for COVID-19 was high. The degree of online interest in a country does not clearly reflect the magnitude of their epidemiological indicators. The response time and the lag correlation were greater than in European and Asian countries. Little interest was found for preventive measures. Strong correlation between searches for COVID-19 and daily new cases suggests a predictive utility that should be investigated by further studies.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectorsAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study was conducted guided by the principles of scientific and ethical integrity. Its approval by an ethics committee was not necessary because the data used is anonymous and freely accessible.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesOur raw data is publicly available in Figshare repository: https://doi.org/10.6084/m9.figshare.12644222 https://doi.org/10.6084/m9.figshare.12644222